Dr Tejas P Deliwala Neurological Care is categorized under Neurologists in Morganville, NJ and active since 2007.
Dr Tejas P Deliwala Neurological Care was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Neurologists business, which does work in the B2C market, and is classified as a Neurologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Tejas P Deliwala at the company’s single location by writing to 130 Radcliff Place, Morganville, New Jersey NJ 07751 or by phoning (732) 970-8492. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Dr Tejas P Deliwala Neurological Care |
| Contact Person: | Tejas P Deliwala |
| Address: | 130 Radcliff Place, Morganville, New Jersey 07751 |
| Phone Number: | (732) 970-8492 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Neurologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Dr Tejas P Deliwala Neurological Care was started in 2007 to provide professional Neurologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Tejas P Deliwala for inquiries that concern Dr Tejas P Deliwala Neurological Care by calling the company number (732) 970-8492, as your correspondence is most welcome. Additionally, the physical location of the single location of Dr Tejas P Deliwala Neurological Care can be found at the coordinates as well as the street address 130 Radcliff Place in Morganville, New Jersey 07751.
For its online presence, you may visit Dr Tejas P Deliwala Neurological Care’s website at and engage with its social media outlets through on Twitter and on Facebook.